Lung Cancer

Lung cancer is a malignant tumor arising from the bronchial or pulmonary epithelium. It is categorized primarily into Non-Small Cell Lung Cancer (NSCLC), which accounts for 85% of cases (adenocarcinoma, squamous cell carcinoma, large cell carcinoma), and Small Cell Lung Cancer (SCLC), which is characterized by rapid growth and early metastasis.

The primary cause is the accumulation of genetic mutations in bronchial epithelial cells due to chronic exposure to carcinogens. Tobacco smoke remains the leading cause, followed by radon exposure, occupational carcinogens (asbestos, arsenic, chromium), and air pollution. Genetic predisposition, such as EGFR or ALK mutations, also plays a critical role in pathogenesis.

Pathogenesis involves the sequential activation of oncogenes (e.g., KRAS, EGFR) and inactivation of tumor suppressor genes (e.g., TP53). This leads to uncontrolled cell division, invasion of the basement membrane, angiogenesis, and potential lymphatic or hematogenous dissemination to distant sites like the brain, bones, and liver.

Lung cancer is the second most common cancer worldwide and the leading cause of cancer-related mortality. Incidence peaks in adults aged 55–7

1. While historically male-predominant due to smoking habits, gender gaps have narrowed significantly.

• Chronic tobacco consumption
• Exposure to secondhand smoke
• Radon gas exposure
• Family history
• Occupational exposure (asbestos, silica)
• Chronic obstructive pulmonary disease (COPD)

A. Early Symptoms

• Persistent cough


• Mild exertional dyspnea


• Hemoptysis B. Common Symptoms


• Chest pain


• Unexplained weight loss


• Hoarseness


• Recurrent respiratory infections C. Advanced Symptoms


• Bone pain (metastasis)


• Neurological deficits (brain metastasis)


• Superior Vena Cava (SVC) obstruction syndrome D. Emergency Symptoms


• Massive hemoptysis


• Acute respiratory failure


• Spinal cord compression

• Inspection: Clubbing, supraclavicular lymphadenopathy
• Auscultation: Localized wheezing, decreased breath sounds, crackles
• Vital signs: Tachycardia, tachypnea, hypoxia

A. Clinical Assessment: History and physical examination.
B. Laboratory Testing: CBC, metabolic panel, liver function tests.
C. Imaging Studies: CXR, low-dose CT (LDCT).
D. Functional Tests: Pulmonary Function Tests (PFTs) for surgical candidacy.
E. Biopsy Findings: Histopathological classification.
F. Genetic Testing: EGFR, ALK, ROS1, PD-L1 expression.
G. Differential Diagnosis: Tuberculosis, pneumonia, pulmonary fibrosis.

Complete Blood Count (CBC)
Type: Blood Test
Purpose: Assess for anemia or elevated leukocytes.
Expected Findings: Normocytic anemia or leukocytosis.
Interpretation: Indicates systemic malignancy or secondary infection.

Chest CT (Contrast-enhanced): Gold standard for staging and anatomical localization.
PET-CT: Evaluates metabolic activity and distant metastatic spread.

Tuberculosis (fever/hemoptysis), Lung Abscess (cavitary lesion), Benign pulmonary nodules (granulomas).

Superior Vena Cava syndrome, paraneoplastic syndromes, pleural effusion, malnutrition, cachexia.

A. Lifestyle Modifications: Smoking cessation.
B. Preventive Measures: Radon testing, occupational safety.
C. Medical Treatment: - Chemotherapy (e.g., Cisplatin)

• Targeted Therapy (e.g., Osimertinib for EGFR)


• Immunotherapy (e.g., Pembrolizumab)

Prognosis is stage-dependent. 5-year survival for localized NSCLC is approximately 60%, while metastatic SCLC is <5%.

Screening for high-risk smokers using LDCT, avoiding tobacco and environmental toxins.

The following homeopathic remedies have been historically indicated for symptoms associated with Lung Cancer. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

📊 Advanced Respiratory & Lung Health Analyzer

Evaluates COPD risk, Asthma control, estimated Lung Age, and overall respiratory capacity based on symptom frequency, smoking history, and pack-year exposure.